# US 2008/0188414 A1 · Factor IX moiety-polymer conjugates having a releasable linkage

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2008/0188414 A1
- Document ID: US20080188414A1
- Status: Published application
- Kind: A1
- Application number: 12/006,073
- Filed: 2007-12-27
- Published: 2008-08-07
- Earliest claimed: 2006-12-27
- Assignees: Nektar Therapeutics AL, Corporation
- Inventors: Mary J. Bossard; Gayle Stephenson
- Web page: https://patentgrep.com/patent/US20080188414A1

## CPC

- C08G 65/33337: {cyclic}
- A61K 47/60: the organic macromolecular compound being a polyoxyalkylene oligomer, polymer or dendrimer, e.g. PEG, PPG, PEO or polyglycerol
- A61P 7/00: Drugs for disorders of the blood or the extracellular fluid
- A61P 7/04: Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
- C08G 65/3332: {containing carboxamide group}
- C08G 65/33396: {having oxygen in addition to nitrogen}
- C08G 65/3348: {containing nitrogen in addition to sulfur}
- C08L 2203/02: for biomedical use
- C08G: MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- A61P: SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- C08L: COMPOSITIONS OF MACROMOLECULAR COMPOUNDS (compositions based on polymerisable monomers C08F, C08G; artificial filaments or fibres D01F; textile treating compositions D06)

## Abstract

The present invention provides Factor IX moiety-polymer conjugates having a releaseable linkage. Methods of making conjugates, methods for administering conjugates, are also provided.

## Claims

### Claim 1

A compound having the following structure:
wherein:
POLY1 is a first water-soluble polymer;
POLY2 is a second water-soluble polymer;
X1 is a first spacer moiety;
X2 is a second spacer moiety;
Hα is an ionizable hydrogen atom;
R1 is H or an organic radical;
R2 is H or an organic radical;
(a) is either zero or one;
(b) is either zero or one;
Re1, when present, is a first electron altering group;
Re2, when present, is a second electron altering group;
Y1 is O or S;
Y2 is O or s; and
(F9) is a residue of an amine-containing Factor IX moiety.

### Claim 2 (depends on 1)

The compound of claim 1, wherein the amine-containing Factor IX moiety is recombinant Factor Ix.

### Claim 3 (depends on 2)

The compound of claim 2, wherein the recombinant Factor IX is human recombinant Factor IX.

### Claim 4 (depends on 1)

The compound of claim 1, wherein the first water-soluble polymer is a poly(alkylene oxide) and the second water-soluble polymer is a poly(alkylene oxide).

### Claim 5 (depends on 1)

The compound of claim 1, wherein the first water-soluble polymer has a weight-average molecular weight of between 10,000 Daltons to 85,000 Daltons and the second water-soluble polymer has a weight-average molecular weight of between 10,000 Daltons to 85,000 Daltons.

### Claim 6 (depends on 1)

The compound of claim 1, having a structure selected from the group consisting of:
wherein, for each structure and in each instance, (n) is independently an integer from 4 to 1500, and (F9) is a residue of an amine-containing Factor IX moiety.

### Claim 7 (depends on 1)

The compound of claim 1, having the following structure:
wherein, (F9) is a residue of an amine-containing Factor IX moiety and (n), in each instance, is independently from 4 to 1500.

### Claim 8 (depends on 1)

The compound of claim 1, having the following structure:
wherein, (F9) is a residue of an amine-containing Factor IX moiety and (n), in each instance, is independently from 4 to 1500.

### Claim 9 (depends on 7, 8)

The compound of one of claim 7 and claim 8, wherein the Factor IX moiety is human recombinant Factor IX.

### Claim 10

A method comprising contacting a polymeric reagent to an amine-containing Factor IX moiety under conditions suitable to form a covalent attachment between the polymeric reagent and the biologically active agent, wherein the polymeric reagent has the following structure:
wherein:
POLY1 is a first water-soluble polymer;
POLY2 is a second water-soluble polymer;
X1 is a first spacer moiety;
X2 is a second spacer moiety;
Hα is an ionizable hydrogen atom;
R1 is H or an organic radical;
R2 is H or an organic radical;
(a) is either zero or one;
(b) is either zero or one;
Re1, when present, is a first electron altering group;
Re2, when present, is a second electron altering group; and
(FG) is a functional group capable of reacting with an amino group of an active agent to form a releasable linkage.

### Claim 11 (depends on 10)

The method of claim 10, wherein the releasable linkage is a carbamate linkage.

### Claim 12 (depends on 10)

The method of claim 10, wherein the polymeric reagent has a structure selected from the group consisting of:
wherein, for each structure and in each instance, (n) is independently an integer from 4 to 1500.

### Claim 13 (depends on 12)

The method of claim 12, wherein Factor IX moiety is human recombinant Factor IX.

### Claim 14 (depends on 1)

A composition comprising a compound of any one of claims 1 though 9 and a pharmaceutically acceptable excipient.

### Claim 15 (depends on 14)

A method comprising administering a composition of claim 14 to a patient.
